Thursday, 11 June 2026 | 13:35 - 14:00
Antibody Horizons: Innovation, Translation and Clinical Impact – Hilde Revets, PHiRA Consulting/VUB
Antibody Horizons: Innovation, Translation and Clinical Impact” gives an easy to understand look at how new antibody technologies are making treatments more precise and effective. It also explains how these advances move from the lab to real patients, and what challenges—like safety, manufacturing, and cost—need to be solved to bring these therapies to everyone who needs them.